Malignant Pleural Disease
1 clinical trials · Condition
◉ Watch Malignant Pleural Disease
| Record | Firm | Date |
|---|---|---|
| Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin (NCT02414269) | Memorial Sloan Kettering Cancer Center | 2015-05-01 |
Track Malignant Pleural Disease automatically
Every clearance here is in the API, with alerts when new ones post.